Oncology Overview Highlights
- 5,000+ patients enrolled per year across Sarah Cannon
- 600+ first-in-human clinical trials conducted
- Clinical trial leader in the majority of approved cancer therapies over the last 10 years
- 3,000+ patients enrolled in immunotherapy trials to date
SMO Overview
Sarah Cannon’s Site Management Organization (SMO) offers operational, regulatory and other centralized research support services for sites on industry-sponsored and investigator-initiated trials. With access to a broad patient base, the SMO conducts and supports phase I through III and outcomes-based trials throughout its network of sites.
The SMO offers support services for trials across tumor types including complex GI, lung, breast/gynecologic, central nervous system, genitourinary, melanoma and blood cancers.
Centralized Support Services:
- Program Development & Start-up
- Contracting & Financial Services
- Regulatory & Safety
- Clinical Operations Support
- Global Quality & Education
- Technology Integration & Support
Our Differentiators:
- Rapid Study Activation Timelines
- Community Clinic-Based Model at Sarah Cannon Sites Provides Access to Larger Numbers of Patients
- Efficiencies With Budget, Contract, and Informed Consent Negotiations
- Utilization of Central IRBs
- Standardized SOPs and Quality Metrics Across All Sarah Cannon Sites
